Lipoprotein(a) and proprotein convertase subtilisin/kexin type 9 inhibitors.

Julius, U; Tselmin, S; Schatz, U; Fischer, S; Bornstein, S R

Lipoprotein(a) and proprotein convertase subtilisin/kexin type 9 inhibitors.

Julius, U; Tselmin, S; Schatz, U; Fischer, S; Bornstein, S R.

Afiliação

Julius U; Lipidology and Center for Extracorporeal Treatment, Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Fetscherstr. 74, 01307, Dresden, Germany. ulrich.julius@uniklinikum-dresden.de.
Tselmin S; Lipidology and Center for Extracorporeal Treatment, Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Fetscherstr. 74, 01307, Dresden, Germany.
Schatz U; Lipidology and Center for Extracorporeal Treatment, Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Fetscherstr. 74, 01307, Dresden, Germany.
Fischer S; Lipidology and Center for Extracorporeal Treatment, Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Fetscherstr. 74, 01307, Dresden, Germany.
Bornstein SR; Lipidology and Center for Extracorporeal Treatment, Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Fetscherstr. 74, 01307, Dresden, Germany.

Clin Res Cardiol Suppl ; 14(Suppl 1): 45-50, 2019 Apr.

Article em En | MEDLINE | ID: mdl-30838555

Assuntos

Doenças Cardiovasculares/prevenção & controle; LDL-Colesterol/sangue; Lipoproteína(a)/sangue; Inibidores de PCSK9; Anticorpos Monoclonais Humanizados/administração & dosagem; Anticorpos Monoclonais Humanizados/farmacologia; Anticolesterolemiantes/administração & dosagem; Anticolesterolemiantes/farmacologia; Aterosclerose/sangue; Aterosclerose/prevenção & controle; Doenças Cardiovasculares/sangue; Humanos; Receptores de LDL/metabolismo; Fatores de Risco

Palavras-chave

Cardiovascular events; LDL cholesterol; Lipoprotein apheresis; Lipoprotein(a); PCSK9 inhibitors

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Lipoproteína(a) / Inibidores de PCSK9 / LDL-Colesterol Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google